Correlation Between Alphabet and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both Alphabet and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alphabet and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alphabet Inc Class C and Molecular Partners AG, you can compare the effects of market volatilities on Alphabet and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alphabet with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alphabet and Molecular Partners.
Diversification Opportunities for Alphabet and Molecular Partners
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Alphabet and Molecular is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Alphabet Inc Class C and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Alphabet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alphabet Inc Class C are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Alphabet i.e., Alphabet and Molecular Partners go up and down completely randomly.
Pair Corralation between Alphabet and Molecular Partners
Given the investment horizon of 90 days Alphabet is expected to generate 1.07 times less return on investment than Molecular Partners. But when comparing it to its historical volatility, Alphabet Inc Class C is 4.73 times less risky than Molecular Partners. It trades about 0.1 of its potential returns per unit of risk. Molecular Partners AG is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 564.00 in Molecular Partners AG on September 3, 2024 and sell it today you would lose (24.00) from holding Molecular Partners AG or give up 4.26% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Alphabet Inc Class C vs. Molecular Partners AG
Performance |
Timeline |
Alphabet Class C |
Molecular Partners |
Alphabet and Molecular Partners Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Alphabet and Molecular Partners
The main advantage of trading using opposite Alphabet and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alphabet position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.The idea behind Alphabet Inc Class C and Molecular Partners AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |